Graviti Pharmaceuticals Private Limited: Drug Recall
Recall #D-0293-2026 · 01/10/2026
Class II: Risk
Recall Details
- Recall Number
- D-0293-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Graviti Pharmaceuticals Private Limited
- Status
- Ongoing
- Date Initiated
- 01/10/2026
- Location
- Hyderabad, India
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4212 bottles
Reason for Recall
Presence of Foreign Substance
Product Description
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
Distribution Pattern
U.S. Nationwide
Other Recalls by Graviti Pharmaceuticals Private Limited
- Class II: Risk 09/15/2025
View all recalls by Graviti Pharmaceuticals Private Limited →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.